Skip Navigation


JAC Advance Access originally published online on December 19, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
53/2/405    most recent
dkh051v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bujdáková, H.
Right arrow Articles by Drahovská, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bujdáková, H.
Right arrow Articles by Drahovská, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2004) 53, 405-406
© 2004 The British Society for Antimicrobial Chemotherapy

Correspondence

Molecular characterization of hospital vancomycin-resistant Enterococcus faecalis isolated in Slovakia

Helena Bujdáková1,*, Miriam Filipová1, Anna Lísková2 and Hana Drahovská3

1 Comenius University, Faculty of Natural Sciences, Department of Microbiology and Virology, Mlynská dolina B-2, 842 15 Bratislava; 2 Institute of Clinical Microbiology, Hospital Nitra; 3 Comenius University, Faculty of Natural Sciences, Department of Molecular Biology, Bratislava, Slovak Republic

Keywords: Enterococcus, vancomycin, resistance, VRE

The first 10% of the full text of this article appears below.

Sir,

Vancomycin-resistant enterococci (VRE) represent a reservoir of glycopeptide resistance in hospital patients, especially in high-risk wards.1 In Slovakia, the incidence of VRE has not yet been published, although Bíliková et al.2 reported the participation of enterococci, with susceptibility to vancomycin over 16 mg/L, in bacteraemias in six Slovak hospitals. Thus, monitoring of glycopeptide resistance in enterococci is crucial because . . . [Full Text of this Article]

Acknowledgements


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?